Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lactobacillus fermentum CECT 5716 Reduces Staphylococcus Load in the Breastmilk of Lactating Mothers Suffering Breast Pain: A Randomized Controlled Trial.
Maldonado-Lobón JA, Díaz-López MA, Carputo R, Duarte P, Díaz-Ropero MP, Valero AD, Sañudo A, Sempere L, Ruiz-López MD, Bañuelos Ó, Fonollá J, Olivares Martín M. Maldonado-Lobón JA, et al. Among authors: valero ad. Breastfeed Med. 2015 Nov;10(9):425-32. doi: 10.1089/bfm.2015.0070. Epub 2015 Sep 9. Breastfeed Med. 2015. PMID: 26352805 Clinical Trial.
Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants.
Maldonado J, Cañabate F, Sempere L, Vela F, Sánchez AR, Narbona E, López-Huertas E, Geerlings A, Valero AD, Olivares M, Lara-Villoslada F. Maldonado J, et al. Among authors: valero ad. J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):55-61. doi: 10.1097/MPG.0b013e3182333f18. J Pediatr Gastroenterol Nutr. 2012. PMID: 21873895 Clinical Trial.
Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial.
Gil-Campos M, López MÁ, Rodriguez-Benítez MV, Romero J, Roncero I, Linares MD, Maldonado J, López-Huertas E, Berwind R, Ritzenthaler KL, Navas V, Sierra C, Sempere L, Geerlings A, Maldonado-Lobón JA, Valero AD, Lara-Villoslada F, Olivares M. Gil-Campos M, et al. Among authors: valero ad. Pharmacol Res. 2012 Feb;65(2):231-8. doi: 10.1016/j.phrs.2011.11.016. Epub 2011 Dec 6. Pharmacol Res. 2012. PMID: 22155106 Clinical Trial.
Long-term safety of early consumption of Lactobacillus fermentum CECT5716: A 3-year follow-up of a randomized controlled trial.
Maldonado-Lobón JA, Gil-Campos M, Maldonado J, López-Huertas E, Flores-Rojas K, Valero AD, Rodríguez-Benítez MV, Bañuelos O, Lara-Villoslada F, Fonollá J, Olivares M. Maldonado-Lobón JA, et al. Among authors: valero ad. Pharmacol Res. 2015 May-Jun;95-96:12-9. doi: 10.1016/j.phrs.2015.01.006. Epub 2015 Feb 16. Pharmacol Res. 2015. PMID: 25697549 Clinical Trial.
Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial.
Maldonado J, Gil-Campos M, Maldonado-Lobón JA, Benavides MR, Flores-Rojas K, Jaldo R, Jiménez Del Barco I, Bolívar V, Valero AD, Prados E, Peñalver I, Olivares M. Maldonado J, et al. Among authors: valero ad. BMC Pediatr. 2019 Oct 21;19(1):361. doi: 10.1186/s12887-019-1753-7. BMC Pediatr. 2019. PMID: 31630683 Free PMC article. Clinical Trial.
66 results